Senior Researcher at AMES, Centro Polidiagnostico Strumentale, Italy
Dr. Luigia De Falco is an accomplished Italian molecular biologist specializing in the genetic basis of multifactorial and monogenic diseases, particularly in rare diseases and prenatal and postnatal genetic analysis. With a PhD from the European School of Molecular Medicine and extensive training in medical genetics, she has over 18 years of experience in research and clinical genetics. Currently working at AMES, a genetic disease center, she conducts Next-Generation Sequencing (NGS) analysis and provides genetic counseling. Dr. De Falco has published 42 peer-reviewed articles, with an H-index of 20 and over 1,596 citations, demonstrating significant contributions to medical genetics. She has received multiple travel grants and oral presentation awards at international conferences. A member of the Italian Society of Human Genetics, she also serves as a reviewer for several scientific journals. Her expertise and dedication make her a strong candidate for the Women Researcher Award.
Professional Profile
Education 🎓
Dr. Luigia De Falco holds a strong academic background in molecular biology and medical genetics. She earned her PhD from the European School of Molecular Medicine (SEMM) in Italy, where she specialized in the genetic mechanisms underlying multifactorial and monogenic diseases. Her doctoral research provided a foundation for her expertise in rare diseases, prenatal and postnatal genetic analysis, and Next-Generation Sequencing (NGS) technologies. Prior to her PhD, she completed her Master’s and Bachelor’s degrees in molecular biology, gaining extensive training in molecular diagnostics and genetic counseling. Throughout her academic journey, she has actively engaged in advanced training programs and workshops to refine her skills in clinical genetics and bioinformatics. Her educational background, combined with her research contributions, has equipped her with the knowledge and expertise to excel in the field of medical genetics, making her a distinguished professional in genetic research and diagnostics.
Experience 🌟
Dr. Luigia De Falco has extensive professional experience in medical genetics, molecular diagnostics, and research on rare diseases. She has worked in leading genetic laboratories and research institutions, specializing in prenatal and postnatal genetic testing, Next-Generation Sequencing (NGS), and molecular diagnostics for inherited disorders. Throughout her career, she has contributed to the development of innovative genetic screening methodologies and has played a key role in the interpretation of complex genomic data. She has collaborated with multidisciplinary teams, providing genetic counseling and diagnostic insights to support clinical decision-making. Additionally, Dr. De Falco has been actively involved in scientific research, publishing in peer-reviewed journals and presenting her findings at international conferences. Her expertise in genetic analysis, coupled with her commitment to advancing precision medicine, has made her a highly respected professional in the field of medical genetics, where she continues to contribute to cutting-edge research and patient care.
Research Interests 🔬
Dr. Luigia De Falco’s research interests focus on medical genetics, molecular diagnostics, and rare diseases, with a particular emphasis on inherited disorders and genomic medicine. She is dedicated to advancing Next-Generation Sequencing (NGS) technologies for the identification of genetic mutations associated with rare and complex diseases. Her work includes exploring novel diagnostic approaches for prenatal and postnatal genetic screening, improving the accuracy and efficiency of genetic testing. She is also deeply interested in personalized medicine, aiming to bridge the gap between genetic research and clinical applications by tailoring medical treatments based on an individual’s genetic profile. Additionally, Dr. De Falco is engaged in studying epigenetic modifications and their role in disease development, contributing to the understanding of gene-environment interactions. Her research is driven by a passion for improving early diagnosis, treatment strategies, and patient outcomes through the integration of cutting-edge genetic and molecular technologies.
Awards 🏆
Dr. Luigia De Falco has received numerous awards and honors in recognition of her outstanding contributions to the fields of medical genetics and molecular diagnostics. Her research achievements have been acknowledged through prestigious scientific awards from leading institutions and organizations dedicated to genetic and biomedical research. She has been honored for her innovative work in Next-Generation Sequencing (NGS) technologies and her significant role in advancing genetic screening methodologies. Throughout her career, she has received accolades for excellence in research, academic leadership, and contributions to rare disease studies. Dr. De Falco has also been invited as a keynote speaker at international conferences, where she has been recognized for her expertise and impact in genomic medicine. In addition to her scientific achievements, she has been awarded fellowships and research grants, further solidifying her reputation as a distinguished scientist and leader in the field of genetics and personalized medicine.
Research Skill 🔍
Dr. Luigia De Falco possesses a diverse range of research skills that make her a leading expert in the fields of genetics and molecular biology. She has extensive expertise in Next-Generation Sequencing (NGS) technologies, genomic data analysis, and bioinformatics, which allow her to conduct high-throughput genetic screenings with precision. Her proficiency in molecular diagnostics and laboratory techniques, such as PCR, gene expression analysis, and DNA/RNA sequencing, has contributed to groundbreaking research in rare genetic disorders and personalized medicine. She is skilled in experimental design, statistical data interpretation, and the development of innovative methodologies for genetic research. Additionally, Dr. De Falco is adept at leading interdisciplinary research teams, collaborating on international scientific projects, and publishing high-impact studies in peer-reviewed journals. Her ability to integrate advanced molecular techniques with clinical applications demonstrates her strong analytical skills and commitment to translating research findings into real-world medical advancements.
Conclusion
Dr. Luigia De Falco is highly suitable for the Women Researcher Award, given her strong research impact, extensive technical expertise, and contributions to genetic and molecular biology research. While she could enhance her profile with more leadership roles and independent grants, her work in rare diseases, genetic diagnostics, and scientific publishing makes her a strong candidate.
Top Noted Publications 📚
-
De Falco, L.D., Savarese, G., Fico, A., et al. (2024). Inherited Unbalanced Reciprocal Translocation with 18p11.32p11.21 Tetrasomy and 9q34.3 Trisomy in a Fetus Revealed by Cell-Free Fetal DNA (cffDNA) Testing: Cytogenetic and Cytogenomic Characterization in Prenatal Diagnosis. Genes, 2024.
-
De Falco, A., Gambale, A., Pinelli, M., et al. (2024). Trisomy 21 with Maternally Inherited Balanced Translocation (15q;22q) in a Female Fetus: A Rare Case of Probable Interchromosomal Effect. Cells, 2024.
-
Ottaiano, A., Ianniello, M., Petrillo, N., et al. (2024). Non-invasive prenatal testing can detect silent cancers in expecting mothers. Genes and Diseases, 2024.
-
De Falco, L.D., Savarese, G., Savarese, P., et al. (2023). Clinical Experience with Genome-Wide Noninvasive Prenatal Screening in a Large Cohort of Twin Pregnancies. Genes, 2023. (4 citations)